United States · FDA National Drug Code directory
XPHOZAH 30 mg
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73154-130_4555be24-05c0-4145-80c4-2fbd64d08e52
- Product NDC
- 73154-130
- Form
- TABLET, FILM COATED
- Composition / generic term
- Tenapanor
- Labeler
- Ardelyx, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20231017
- Source listing expiry
- 20261231
Source-listed ingredients
- TENAPANOR HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET, FILM COATED in 1 BOTTLE (73154-130-14) · 73154-130-14
- 60 TABLET, FILM COATED in 1 BOTTLE (73154-130-60) · 73154-130-60
- 14 TABLET, FILM COATED in 1 BOTTLE (73154-130-99) · 73154-130-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →